Gillian Bethune

629 total citations
18 papers, 483 citations indexed

About

Gillian Bethune is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Gillian Bethune has authored 18 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Cancer Research. Recurrent topics in Gillian Bethune's work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Breast Cancer Treatment Studies (4 papers). Gillian Bethune is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Breast Cancer Treatment Studies (4 papers). Gillian Bethune collaborates with scholars based in Canada and United States. Gillian Bethune's co-authors include Neale D. Ridgway, Drew Bethune, Zhaolin Xu, Penny J. Barnes, Tallal Younis, Daniel Rayson, Kara Thompson, Ricardo Rendon, Jennifer Merrimen and David Bell and has published in prestigious journals such as Annals of Oncology, Urology and Breast Cancer Research and Treatment.

In The Last Decade

Gillian Bethune

18 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Bethune Canada 8 222 189 149 119 86 18 483
Pasqualina Giordano Italy 14 270 1.2× 162 0.9× 162 1.1× 50 0.4× 65 0.8× 31 505
Giuseppe Gullo Ireland 13 368 1.7× 271 1.4× 151 1.0× 154 1.3× 88 1.0× 42 692
Andrew Elliott United States 10 260 1.2× 191 1.0× 146 1.0× 89 0.7× 65 0.8× 99 483
Djamila Ouaret United Kingdom 10 281 1.3× 278 1.5× 142 1.0× 147 1.2× 37 0.4× 15 583
Bernhard Heinrich Germany 14 439 2.0× 160 0.8× 187 1.3× 66 0.6× 129 1.5× 36 630
Jan Nyrop Jakobsen Denmark 10 195 0.9× 153 0.8× 284 1.9× 111 0.9× 53 0.6× 18 474
Karel Cwiertka Czechia 10 247 1.1× 115 0.6× 123 0.8× 108 0.9× 40 0.5× 45 436
Tianqing Chu China 12 317 1.4× 227 1.2× 277 1.9× 163 1.4× 33 0.4× 46 606
Kerstin Unterschemmann Germany 6 171 0.8× 220 1.2× 95 0.6× 205 1.7× 81 0.9× 8 485
Arpita Desai United States 10 165 0.7× 229 1.2× 185 1.2× 116 1.0× 33 0.4× 38 451

Countries citing papers authored by Gillian Bethune

Since Specialization
Citations

This map shows the geographic impact of Gillian Bethune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Bethune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Bethune more than expected).

Fields of papers citing papers by Gillian Bethune

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Bethune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Bethune. The network helps show where Gillian Bethune may publish in the future.

Co-authorship network of co-authors of Gillian Bethune

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Bethune. A scholar is included among the top collaborators of Gillian Bethune based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Bethune. Gillian Bethune is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Bharadwaj, Alamelu G., Raj Pranap Arun, Brianne M. Cruickshank, et al.. (2023). ALDH1A3 promotes invasion and metastasis in triple‐negative breast cancer by regulating the plasminogen activation pathway. Molecular Oncology. 18(1). 91–112. 4 indexed citations
3.
Rasmussen, Sean A., Valerie Jones Taylor, Alexi P. Surette, Penny J. Barnes, & Gillian Bethune. (2022). Using Deep Learning to Predict Final HER2 Status in Invasive Breast Cancers That are Equivocal (2+) by Immunohistochemistry. Applied immunohistochemistry & molecular morphology. 30(10). 668–673. 7 indexed citations
4.
Castonguay, Mathieu, et al.. (2022). HER2 testing in metastatic breast cancer – Is reflex ISH testing necessary on HER2 IHC-equivocal (2+) cases?. Annals of Diagnostic Pathology. 59. 151953–151953. 2 indexed citations
5.
Surette, Alexi P., Byong Hoon Yoo, Tallal Younis, et al.. (2021). Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies. Breast Cancer Research and Treatment. 187(3). 743–758. 8 indexed citations
6.
Taylor, Valerie Jones, et al.. (2021). Assessment of HER2 using the 2018 ASCO/CAP guideline update for invasive breast cancer: a critical look at cases classified as HER2 2+ by immunohistochemistry. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(1). 23–31. 4 indexed citations
7.
Bethune, Gillian, et al.. (2020). Cystic neutrophilic granulomatous mastitis – a review of 12 consecutive cases. Histopathology. 77(5). 781–787. 15 indexed citations
8.
Chang, Martin C., et al.. (2019). Hep par 1 immunohistochemistry in glycogen-rich clear cell carcinoma of the breast. Annals of Oncology. 30. iii23–iii23. 1 indexed citations
9.
Bethune, Gillian, et al.. (2019). Isolated Tumor Cells in Sentinel Lymph Nodes of Primary Invasive Breast Carcinoma: A Cohort Analysis. Clinical Breast Cancer. 19(4). 286–291. 2 indexed citations
10.
Yoo, Byong Hoon, Olivier Masson, Alexi P. Surette, et al.. (2018). ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth. Breast Cancer Research. 20(1). 151–151. 11 indexed citations
12.
Bethune, Gillian, J. Brendan Mullen, & Martin C. Chang. (2015). Detecting intratumoral heterogeneity in routine breast-HER2 testing: low yield of testing multiple blocks. Annals of Diagnostic Pathology. 19(6). 385–390. 4 indexed citations
14.
Bethune, Gillian, J. Brendan M. Mullen, & Martin C. Chang. (2013). HER2 Testing of Multifocal Invasive Breast Carcinoma. American Journal of Clinical Pathology. 140(4). 588–592. 8 indexed citations
15.
Bethune, Gillian, et al.. (2012). Clinical and Pathologic Factors of Prognostic Significance in Penile Squamous Cell Carcinoma in a North American Population. Urology. 79(5). 1092–1097. 34 indexed citations
16.
Bethune, Gillian, et al.. (2011). A Novel Inflammatory Reaction in a Tattoo: Challenge. American Journal of Dermatopathology. 33(7). 740–741. 9 indexed citations
17.
Bethune, Gillian, et al.. (2011). A Novel Inflammatory Reaction in a Tattoo: Answer. American Journal of Dermatopathology. 33(7). 749–749. 1 indexed citations
18.
Bethune, Gillian, Drew Bethune, Neale D. Ridgway, & Zhaolin Xu. (2010). Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.. PubMed. 2(1). 48–51. 312 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026